BLOZF
Price
$0.44
Change
+$0.05 (+12.82%)
Updated
Feb 3 closing price
Capitalization
53.12M
Intraday BUY SELL Signals
NUWE
Price
$3.40
Change
-$0.50 (-12.85%)
Updated
Feb 4, 02:52 PM (EDT)
Capitalization
3.62M
Intraday BUY SELL Signals
Interact to see
Advertisement

BLOZF vs NUWE

Header iconBLOZF vs NUWE Comparison
Open Charts BLOZF vs NUWEBanner chart's image
Cannabix Technologies
Price$0.44
Change+$0.05 (+12.82%)
Volume$106.02K
Capitalization53.12M
Nuwellis
Price$3.40
Change-$0.50 (-12.85%)
Volume$1K
Capitalization3.62M
BLOZF vs NUWE Comparison Chart in %
BLOZF
Daily Signal:
Gain/Loss:
NUWE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLOZF vs. NUWE commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLOZF is a Hold and NUWE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BLOZF: $0.44 vs. NUWE: $3.89)
Brand notoriety: BLOZF and NUWE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BLOZF: 80% vs. NUWE: 12%
Market capitalization -- BLOZF: $53.12M vs. NUWE: $3.62M
BLOZF [@Medical/Nursing Services] is valued at $53.12M. NUWE’s [@Medical/Nursing Services] market capitalization is $3.62M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $189.57B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLOZF’s FA Score shows that 0 FA rating(s) are green whileNUWE’s FA Score has 1 green FA rating(s).

  • BLOZF’s FA Score: 0 green, 5 red.
  • NUWE’s FA Score: 1 green, 4 red.
According to our system of comparison, NUWE is a better buy in the long-term than BLOZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLOZF’s TA Score shows that 2 TA indicator(s) are bullish while NUWE’s TA Score has 7 bullish TA indicator(s).

  • BLOZF’s TA Score: 2 bullish, 4 bearish.
  • NUWE’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NUWE is a better buy in the short-term than BLOZF.

Price Growth

BLOZF (@Medical/Nursing Services) experienced а -0.50% price change this week, while NUWE (@Medical/Nursing Services) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +14.02%.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLOZF($53.1M) has a higher market cap than NUWE($3.62M). NUWE YTD gains are higher at: 123.563 vs. BLOZF (4.163). NUWE has higher annual earnings (EBITDA): -5.75M vs. BLOZF (-6.14M). NUWE has more cash in the bank: 3.09M vs. BLOZF (1.6M). BLOZF has less debt than NUWE: BLOZF (88.4K) vs NUWE (383K). NUWE has higher revenues than BLOZF: NUWE (8.17M) vs BLOZF (123K).
BLOZFNUWEBLOZF / NUWE
Capitalization53.1M3.62M1,467%
EBITDA-6.14M-5.75M107%
Gain YTD4.163123.5633%
P/E RatioN/A0.01-
Revenue123K8.17M2%
Total Cash1.6M3.09M52%
Total Debt88.4K383K23%
FUNDAMENTALS RATINGS
BLOZF vs NUWE: Fundamental Ratings
BLOZF
NUWE
OUTLOOK RATING
1..100
434
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5737
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
4350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NUWE's Valuation (26) in the Medical Specialties industry is significantly better than the same rating for BLOZF (97) in the null industry. This means that NUWE’s stock grew significantly faster than BLOZF’s over the last 12 months.

NUWE's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BLOZF (100) in the null industry. This means that NUWE’s stock grew similarly to BLOZF’s over the last 12 months.

NUWE's SMR Rating (100) in the Medical Specialties industry is in the same range as BLOZF (100) in the null industry. This means that NUWE’s stock grew similarly to BLOZF’s over the last 12 months.

NUWE's Price Growth Rating (37) in the Medical Specialties industry is in the same range as BLOZF (57) in the null industry. This means that NUWE’s stock grew similarly to BLOZF’s over the last 12 months.

NUWE's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as BLOZF (100) in the null industry. This means that NUWE’s stock grew similarly to BLOZF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLOZFNUWE
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BLOZF
Daily Signal:
Gain/Loss:
NUWE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVPAF13.631.07
+8.52%
Ivanhoe Mines Ltd.
RCGCF0.130.01
+7.38%
ROSCAN GOLD CORP.
AMKYF20.85N/A
N/A
Abc Mart, Inc.
KCRD0.03N/A
N/A
Kindcard Inc.
GDQMF1.59-0.03
-1.95%
Goldquest Mining Corp.

BLOZF and

Correlation & Price change

A.I.dvisor tells us that BLOZF and PXMBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLOZF and PXMBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLOZF
1D Price
Change %
BLOZF100%
+2.18%
PXMBF - BLOZF
24%
Poorly correlated
N/A
NUWE - BLOZF
22%
Poorly correlated
+1.04%
ANPCF - BLOZF
21%
Poorly correlated
N/A
BRSYF - BLOZF
4%
Poorly correlated
N/A
BBLG - BLOZF
4%
Poorly correlated
-3.07%
More

NUWE and

Correlation & Price change

A.I.dvisor tells us that NUWE and VTAK have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and VTAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
+1.04%
VTAK - NUWE
30%
Poorly correlated
-2.13%
VAPO - NUWE
30%
Poorly correlated
N/A
CORBF - NUWE
24%
Poorly correlated
N/A
PRE - NUWE
24%
Poorly correlated
+0.31%
BNR - NUWE
23%
Poorly correlated
-15.00%
More